ANI Pharmaceuticals Reports Positive Phase 4 Trial Results for Uveitis Treatment

ANI Pharmaceuticals has revealed promising six-month data from its SYNCHRONICITY trial, showing substantial benefits for patients with chronic non-infectious uveitis. The results could reshape treatment approaches for this serious eye condition.